Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-185636
Filing Date
2017-05-26
Accepted
2017-05-26 16:31:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d404725ds3.htm S-3 363801
2 EX-4.8 d404725dex48.htm EX-4.8 248280
3 EX-4.10 d404725dex410.htm EX-4.10 249673
4 EX-5.1 d404725dex51.htm EX-5.1 23174
5 EX-12.1 d404725dex121.htm EX-12.1 4321
6 EX-23.2 d404725dex232.htm EX-23.2 1729
7 GRAPHIC g404725g85h57.jpg GRAPHIC 43168
  Complete submission text file 0001193125-17-185636.txt   951572
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-218294 | Film No.: 17874397
SIC: 2836 Biological Products, (No Diagnostic Substances)